Rohan R Katipally
Overview
Explore the profile of Rohan R Katipally including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Katipally R, Spurr L, Gutiontov S, Turchan W, Connell P, Juloori A, et al.
JCO Precis Oncol
. 2023 Jan;
7:e2200273.
PMID: 36603171
Purpose: Molecular factors predicting relapse in early-stage non-small-cell lung cancer (ES-NSCLC) are poorly understood, especially in inoperable patients receiving radiotherapy (RT). In this study, we compared the genomic profiles of...
12.
Katipally R, Olson A, Chmura S
Int J Radiat Oncol Biol Phys
. 2022 Nov;
114(5):840-842.
PMID: 36395805
No abstract available.
13.
Pathmarajah T, Katipally R, Flores-Martinez E, Farrey K, Korpics M, Sivananthan A, et al.
J Radiosurg SBRT
. 2022 Oct;
8(2):151-153.
PMID: 36275126
No abstract available.
14.
Spurr L, Martinez C, Katipally R, Iyer S, Pugh S, Bridgewater J, et al.
NPJ Precis Oncol
. 2022 Oct;
6(1):72.
PMID: 36241710
Personalized treatment approaches for patients with limited liver metastases from colorectal cancer are critically needed. By leveraging three large, independent cohorts of patients with colorectal liver metastases (n = 336),...
15.
Juloori A, Katipally R, Lemons J, Singh A, Iyer R, Robbins J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Sep;
115(1):202-213.
PMID: 36108891
Purpose: Immunotherapy has emerged as a promising therapeutic option for advanced or unresectable hepatocellular carcinoma (HCC). However, survival remains poor with only a subset of patients deriving benefit. This trial...
16.
Lyden D, Ghajar C, Correia A, Aguirre-Ghiso J, Cai S, Rescigno M, et al.
Cancer Cell
. 2022 Aug;
40(8):787-791.
PMID: 35944497
Metastasis, the major cause of cancer death, represents one of the major challenges in oncology. Scientists are still trying to understand the biological basis underlying the dissemination and outgrowth of...
17.
Katipally R, Pitroda S, Juloori A, Chmura S, Weichselbaum R
Nat Rev Clin Oncol
. 2022 Jul;
19(9):585-599.
PMID: 35831494
Metastases remain the leading cause of cancer-related mortality. The oligometastasis hypothesis postulates that a spectrum of metastatic spread exists and that some patients with a limited burden of metastases can...
18.
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy
Korpics M, Katipally R, Partouche J, Cutright D, Pointer K, Bestvina C, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jun;
114(4):645-654.
PMID: 35753553
Purpose: Thoracic stereotactic body radiation therapy (SBRT) is associated with high rates of local control but carries a risk of pneumonitis. Immunotherapy is a standard treatment for patients with metastatic...